NEW BRUNSWICK, NJ—Johnson & Johnson, the New Brunswick-based pharmecutical giant, will pay $2.5 billion in lawsuit settlements related to complaints about one of the company's hip replacement implants.
The product, known as Articular Surface Replacement (ASR) was sold to nearly 35,000 people in the United States, and 90,00 people worldwide over the course of eight years. But as many as 8,000 patients have sought the product to be removed or replaced.